alisertib
puma
['alisertib', 'biomarker', 'breast', 'paclitaxel', 'puma', '$pbyi']
$pbyi puma biotechnology announces presentation of biomarker findings from a phase ii study of alisertib with paclitaxel versus paclitaxel alone in metastatic or locally recurrent breast cancer at the 2023 asco annual meeting - 
News and analysis of biomedical, biopharma, biotech, biosciences, pharmaceutical, and technology equities